Health Care & Life Sciences » Pharmaceuticals | Zhejiang Huahai Pharmaceutical Co. Ltd.

Zhejiang Huahai Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,277
2,575
3,473
4,053
4,941
5,036
Cost of Goods Sold (COGS) incl. D&A
1,317
1,471
1,836
2,125
2,277
2,139
Gross Income
960
1,104
1,637
1,928
2,664
2,897
SG&A Expense
527
756
1,100
1,420
1,819
2,389
EBIT
405
327
486
568
852
355
Unusual Expense
10
17
2
-
-
-
Non Operating Income/Expense
10
2
16
42
10
38
Interest Expense
35
29
24
45
65
150
Pretax Income
412
313
524
567
783
174
Income Tax
49
56
87
110
156
22
Equity in Affiliates
-
-
-
-
4
17
Consolidated Net Income
363
257
437
457
624
135
Net Income
359
266
442
501
639
108
Net Income After Extraordinaries
359
266
442
501
639
108
Net Income Available to Common
359
266
442
501
639
108
EPS (Basic)
0.31
0.22
0.36
0.41
0.51
0.09
Basic Shares Outstanding
1,176
1,225
1,226
1,229
1,245
1,248
EPS (Diluted)
0.31
0.22
0.36
0.41
0.51
0.09
Diluted Shares Outstanding
1,177
1,226
1,229
1,234
1,247
1,248
EBITDA
537
479
684
818
1,142
701
Other Operating Expense
29
22
51
60
7
153
Non-Operating Interest Income
19
13
6
3
6
7
Minority Interest Expense
4
9
6
44
16
27

About Zhejiang Huahai Pharmaceutical Co.

View Profile
Address
Xunqiao Town
Linhai Zhejiang 317024
China
Employees -
Website http://www.huahaipharm.com
Updated 07/08/2019
Zhejiang Huahai Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. It also integrates and intermediates formulations such as Active Pharmaceutical Ingredients. Its products include Irbesartan and Hydrochlorothiazide Tablet, Paroxetine Hydrochloride Tablet and Irbesartan Tablet.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.